GAMMA Investing’s Century Therapeutics IPSC Stock Holding History

GAMMA Investing’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.82K	Buy	+1,064	New	+$2.18K	﹤0.01%	3974
2024 Q4	–	Sell	-131	Closed	-$224	–	3804
2024 Q3	$224	Sell	131 -45	-26%	-$88	﹤0.01%	3483
2024 Q2	$449	Sell	176 -119	-40%	-$376	﹤0.01%	3226
2024 Q1	$1.23K	Buy	295 +119	+68%	+$504	﹤0.01%	2897
2023 Q4	$753	Buy	+176	New	+$321	﹤0.01%	2872

Other funds holding IPSC

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

FIA

FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing's IPSC Position: Q3 2026 in Review

GAMMA Investing opened a new position in Century Therapeutics (IPSC) in Q3 2026: 1,064 shares worth $1.82K. The stake represents ﹤0.01% of the portfolio and ranks #3974 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in IPSC as recently as Q3 2024.

GAMMA Investing first reported a position in IPSC in Q4 2023 and has held it in 5 quarters since. 5 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

GAMMA Investing held 1,064 shares of Century Therapeutics worth $1.82K as of Q3 2026.
Century Therapeutics was a new GAMMA Investing position in Q3 2026.
Century Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3974 holding.
GAMMA Investing first reported a position in Century Therapeutics in Q4 2023 and has held it in 5 quarters since.
5 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.